Health Condition 1: L811- Chloasma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: To enrol the patient in the study, the patient must- Have given written consent before any treatment is commenced. Adults aged 18 50 years. Fitzpatrick skin types III V (explained below). No use of depigmenting agents, chemical peels, or laser therapy in the past 3 months.
Exclusion criteria
Exclusion criteria: Exclusion criteria- The following patients will be excluded from the study- Pregnant/lactating women. Allergy to cysteamine or hydroquinone. Active dermatological conditions affecting study results. Patients with unrealistic expectations about the outcome of treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary Outcome Change in MASI score from baseline to 12 weeks. Dermoscopic development through the course of the visits Timepoint: Outcomes measured at 4 weeks, 8 weeks and 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary Outcomes Physician s Global Assessment (PGA) score. Patient satisfaction score (PSS) using a 5-point Likert Scale. Occurrence of adverse effects. Timepoint: At 12 weeks For adverse effects, anytime in the study | — |
Countries
India
Contacts
Krishna Vishwa Vidyapeeth (Deemed to be University),Karad